Introduction
M becoming increasingly used in the UK (Wilcock, 2011) T medications can be prescribed in advance to manage common symptoms at the end of life including pain, nausea and vomiting, anxiety and excessive secretions. They are usually prescribed by a GP, dispensed and then he H immediate access to necessary medications in the home is regarded as a key means of improving symptom management and enabling better end of life care in the community (Carney, 2011 , Lawton et al., 2012 , Faull et al., 2013 , National Institute for Health and Care Excellence, 2015 .
Anticipatory prescribing is seen as enabling professional staff such as community and district nurses (Carney, 2011 Y s and experiences in anticipatory prescribing Seymour, 2013, Eisenhauer et al., 2007) and it is cited as a recommended area of research in the new NICE guideline on caring for the dying (National Institute for Health and Care Excellence, 2015) . A synthesis of the existing related research suggests that nurses may be challenged by a lack of resources, limited knowledge and experience with the relevant medications and power differentials between themselves and medical practitioners (Wilson and Seymour, 2013) . Although local audits have been carried out to assess the implementation of anticipatory prescribing (Carney, 2011 , Carney and MacRobbie, 2008 , Scott-Aiton, 2009 , Amass and Allen, 2005 , Lawton et al., 2012 , there are no larger scale studies in existence.
Insights from a qualitative study by Faull et al. (2013) suggest that anticipatory prescribing is complex and that health care staff have a range of interpretations of what is meant by prescribing in advance. The authors conclude that anticipatory prescribing is a process rather than a one-off event and highlight the need to build relationships between professionals to ensure good communication between teams and across organisational boundaries, including out-of-hours care.
This paper reports the findings of a survey that elicited the views of 575 community/district, nursing home, and palliative care nurses from two UK regions: the East Midlands and Lancaster/South
Cumbria. The aim of the survey was to gain insight into the roles and experiences of a wide range of community nurses in end of life medication decisions. This paper draws on both quantitative and qualitative aspects of the survey to give an overview of the key findings.
Methods
The survey was part of a three phase mixed methods study to examine comm experiences of working with anticipatory prescriptions. Phase one was a literature review of 26 studies from 10 countries (Wilson and Seymour, 2013) . Phase two was a qualitative ethnographic study using interviews and observations (Wilson et al., 2015 , Wilson et al., 2014 . The survey was the third phase of the study, informed by the data gathered in the literature review and ethnography.
The survey questionnaire was developed by the research team supported by an advisory panel with expertise in community and end of life care nursing. A face validity exercise was undertaken with a group of district nurses from the East Midlands. The nurses completed the survey and gave feedback in a focus group on the wording, style, order and appropriateness of the questions. In light of their comments, adjustments were made to the questionnaire.
Survey sample
The survey was conducted in two regions: East Midlands and Lancaster/South Cumbria. T B database of NHS staff was used to select 500 district and community nurses at random in each area.
In addition all specialist palliative care nurses, Macmillan and Marie Curie nurses 1 and managers and matrons of nursing homes were also selected in the two areas. It was recognised that the database would not be completely up to date and search terms might identify some nurses who were not working in the fields required. In order to minimise the number of questionnaires sent to 1 inappropriate people, the lists were all examined by hand by the study team. During this process job and institutional titles were inspected to exclude individuals who were not likely to be involved in caring for adults who had died at home or in a nursing home. For example, we excluded all those located in hospitals or with job titles that would not have a primary focus on palliative care for adults.
Data collection and management
From February to May 2013 a postal questionnaire and two reminders were sent to 1739 individuals.
181 mailings were returned as the individual no longer worked at the institution concerned, leaving a total valid sample of 1558. As questionnaires were returned the data were logged in a database managed through the programme Statistical Package for the Social Sciences (SPSS)©.
Data analysis
Survey data were analysed to produce a series of descriptive statistics supported by the SPSS software. Responses were compared across the three categories of nurses (nursing home nurses, community/district nurses and palliative care nurses). The free text sections were analysed using a thematic analysis (Braun and Clarke, 2006) to allocate codes to the comments made in order to identify patterns. These codes were then grouped and distilled to generate themes. Themes were then compared with the quantitative findings and are used in this paper to add depth. As not all respondents answered all questions, total response rates for individual questions are reported and vary throughout the paper.
Ethical approval
We obtained ethical approval from the National Research Ethics Service (11/EM/0213) and governance approval from the NHS Trusts at each research site.
Findings
The overall response rate was 37% (n=575/1558 Respondents reporting that in no cases were they used (just 8 respondents) worked in care homes
Characteristics of patients where an anticipatory prescription was used
Having answered some general questions about anticipatory prescriptions, respondents were then asked to recall details of one specific patient for whom an anticipatory prescription had been used and to answer a series of further questions about that particular case. Table 1 gives a breakdown of the characteristics of these individual patient cases. W (n=412), 63.8% (n=263) were said to be aged 70 or over. The majority of the patients for whom the use of an anticipatory prescription was recalled were reported by nurses as dying in their own home or care home (96.4%; n=432/448). A primary cause of death was provided for 434 patient cases and in 79.3% (n=344/434) of these, cancer was reported by nurses as the registered cause of death.
Fewer respondents from nursing homes reported that cancer was a cause of death among the patients whom they recalled as receiving anticipatory medications. 
The writing and dispensing of the medications
In general, nurses reported working well with GPs and perceived that they had good access to the medications needed. Figure 1 shows that 79.2% (n=427/539) of nurses reported that they (n= However, it was evident there was Anticipatory prescribing 06/04/2016 7 some variation. A small proportion, 9.6% (n=52/539), agreed that some doctors were reluctant to provide anticipatory prescriptions (see Figure 1) Similarly, a few nurses (8.6%; n=45/525) said that they always or frequently experienced significant difficulties in obtaining the drugs specified in anticipatory prescriptions used in end of life care. For a further 11.2% (n= . However the majority of nurses (80.2%; n=421/525) said they encountered these difficulties Across the three categories of nurses slightly less than one fifth (18.4%; n=97/527) agreed with the anticipatory prescriptions are incorrectly written up by doctors H at the categories of respondents this was reported more frequently by palliative care nurses (24.3%; n=28/115) and community/district nurses (25.7%; n=45/175) than by nursing home nurses (9.7% n=19/195). Comments about these issues were also added in the written section of the survey:
I have real problems with GPs prescribing [end of life] drugs, they are usually unable to estimate doses correctly, have no idea how to prescribe when a patient has a Fentanyl patch T incorrectly. (1019: Palliative care nurse) Anticipatory medications used
Where respondents reported on the care of one specific patient who had been in receipt of anticipatory medications, Midazolam was the drug most commonly reported to have been used in the last month of life of this specific patient. This applied to 81.9% (n=367/448) of the patients where a use of an anticipatory prescription was recalled by nurses. This was followed by Levomepromazine (32.5%; n=143/440) and then Haloperidol (23.9%; n=104/435). Figure 3 shows the percentage of drugs used by category of respondent; nurses in all three categories reported similar patterns of usage.
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Figure 3 -Drugs used by respondent category
Managing the use of anticipatory medications
Having the confidence to make decisions relating to the use of drugs specified in anticipatory prescriptions was considered to be important by 92.0% (n=483/525) of nurses responding to the survey. For example, when reporting the use of Midazolam in specific patient cases, 82.2%
(n=287/349) of the responding nurses felt they had the responsibility of the assessing that response to the drug. 34.1% (n=119/349) of nurses responding to this question about a specific patient care felt this responsibility lay with the GP, and 3.2% (n=11/349) with the specialist palliative care doctor (for this question respondents had the opportunity to select more than one option). Table 2 shows that for these patient cases medications were eithe gradual over the last three days of life, with a strong increase on the last day being rare. home, and palliative care nurses across two regions in England. Initially nurses were asked to report their views about anticipatory prescribing in general; they were then asked to refer to a specific patient whom they recalled had received anticipatory medications and to answer a series of further questions about that patient. The survey shows that nurses report the presence of anticipatory prescriptions as very common indeed. Moreover, when in place these prescriptions were normally used I C (2011) S nurses felt that having anticipatory medications in place enabled them to provide better care and could improve the quality of death.
Our findings indicate that nurses have a number of pivotal and complex roles throughout the (Faull et al., 2013) . The survey findings support those of the qualitative work undertaken in the earlier part of the study and reported elsewhere (Wilson et al., 2015) , and was designed to indicate the prevalence of the issues raised by nurses.
Our findings give some insight into the types of medication used for symptom management and the pattern of their use. Of the 441 specific cases where nurses recalled that a patient had received anticipatory medications, Midazolam was reported as the most commonly used drug, with
Levomepromazine and then Haloperidol used less often. These are often considered to be three of (Wilcock, 2011) . For the individual cases reported it was rare for nurses to recall any sudden increase in dosage of the medications used in the last three days of life; any increases that were recalled were considered by respondents as Nurses responding to the survey reported a particular responsibility for monitoring the results of giving the medications, with GPs and other doctors were less often involved in this. This echoed narratives from nurses in the ethnographic element in phase two of the study, recounting that decisions about the use of anticipatory medications were primarily regarded to be the responsibility of the health care team, and often that of the nurse (Wilson et al., 2015) .
Although for the most part nurses reported that relationships with doctors were working well, a small proportion of respondents reported difficulties, again echoing findings from the ethnography in phase two of the study (Wilson et al., 2015) . Some encountered reluctance in some doctors to provide anticipatory prescriptions. In addition a small number of respondents stated the effectiveness of the process could be challenged by prescriptions that were incorrectly written up by doctors, or by difficulties in obtaining the drugs. These findings resonate with observations by Faull et al. (2013) that there is potential for the process to stall at any stage. Recent guidance from NICE (National Institute for Health and Care Excellence, 2015) suggests that when considering the need for anticipatory medications clinicians should not only weigh up benefits and harms of prescribing in advance, but also recognise the possibility of sudden deterioration and time it might take to obtain medications. Hence the recommendation is that prescriptions be put in place as early as possible, yet remain under review (National Institute for Health and Care Excellence, 2015) .
A small number of qualitative comments by responding nurses indicated that they valued being a nurse prescriber and that this had enhanced their confidence and capacity to provide good care.
W G (2011) audit of nurse independent prescribers supports this, concluding that prescribing by nurses is effective, timely and appropriate, especially during out-of-hours periods.
Limitations
S B
person had moved on since the list was compiled, it seems likely that the response was somewhat skewed towards nurses with more experience, as this statisti B picks up a name and adds it to their database. If true, there would tend to be an underrepresentation of people recently starting in posts, and this group may be more likely to contain nurses who had not worked in the role before. A high proportion of respondents with twenty years or more experience may also indicate that the questionnaire was passed on to nurses with more experience to complete and/or that more experienced nurses were more likely to deal with patients with anticipatory prescriptions in place.
The survey was sent to nurses at a time when end of life care was under a great deal of scrutiny due to a media furore and the subsequent repeal of the Liverpool Care Pathway (https://www.gov.uk/government/publications/review-of-liverpool-care-pathway-for-dyingpatients); this may have led to some nurses being reluctant to share their experiences of using anticipatory medications at the end of life, resulting in a lower response rate, particularly from community/district nurses.
It is important for the reader to note that we did not have direct access to patient data. Nurses were asked to report on one specific case with which they had been involved, we therefore have no , or how accurate was their reporting of medication use.
Conclusion
The survey was able to gain insight into the roles and experiences of a substantial number, and range of nurses working with end of life medications in the community. Survey responses show that anticipatory prescriptions are very common, and once in place are often used. The comments in the survey show that nurses value the provision of anticipatory prescriptions and in general believe them to improve the care they provide for their patients. Although for the most part the relationships with doctors were reported by the nurse respondents as working well, a small proportion recorded difficulties when some doctors were reluctant to provide prescriptions, when prescriptions were incorrectly written up by doctors, or in obtaining drugs. This suggests pharmacists, nurses and GPs need to work together to establish the most appropriate ways of facilitating this process. In qualitative comments several nurses indicated that they valued being a nurse prescriber and that this enhanced their confidence and capacity to provide good care.
Increasing the number of Nurse Independent and Supplementary Prescribers (NISP) may help to support the process of anticipatory prescribing.
